🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
56.28
-1.83 (-3.15%)
Nov 19, 2026, 4:00 PM EST - Market closed

Inspire Medical Systems Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
100.72145.4253.51-21.15-44.88-42.04
Depreciation & Amortization
18.6713.966.552.851.861.22
Loss (Gain) From Sale of Investments
-1.28-2.89-8.86-2.47-00.01
Stock-Based Compensation
116.84130.26116.0182.4751.9726.48
Provision & Write-off of Bad Debts
0.20.2-0.771.61-0.06-
Other Operating Activities
-68.74-82.591.522.130.881.07
Change in Accounts Receivable
3.47-26.23-2.6-30.22-27.02-9.24
Change in Inventory
-37.18-65.18-46.23-225.35-8.75
Change in Accounts Payable
-17.79-3.750.69.314.364.78
Change in Other Net Operating Assets
3.057.7710.522.149.136.36
Operating Cash Flow
134.97116.98130.2524.6511.57-20.12
Operating Cash Flow Growth
0.96%-10.19%428.32%113.09%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-37.08-38.5-39.12-23.63-9.1-4.67
Investment in Securities
34.5159.95-74-271.19-10.533.81
Investing Cash Flow
-2.5721.45-113.12-294.82-19.629.14

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
-----24.5-
Net Debt Issued (Repaid)
-----24.5-
Issuance of Common Stock
5.4214.6127.7731.11259.6214.95
Repurchase of Common Stock
-59.73-198.06-80.17-17.16-0.04-
Financing Cash Flow
-54.32-183.45-52.3913.95235.0814.95

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.13-0.31-0.120.160.08-0.02
Net Cash Flow
77.96-45.34-35.39-256.06227.1323.95

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
97.8978.4891.121.022.47-24.79
Free Cash Flow Growth
-0.94%-13.88%8798.73%-58.59%--
Free Cash Flow Margin
11.11%8.61%11.35%0.16%0.61%-10.62%
Free Cash Flow Per Share
3.382.642.980.040.09-0.91
Levered Free Cash Flow
76.2954.562.720.0317.43-10.69
Unlevered Free Cash Flow
76.3854.5962.730.0318.48-9.36

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.140.140.02-2.321.89
Change in Working Capital
-48.46-87.38-37.71-40.781.81-6.86
SEC Filings: 10-K · 10-Q